Registered entities
CARISMA THERAPEUTICS INC
Reg. No. 300993121United States
Carisma Therapeutics Inc.
Reg. No. 30-0993121United States
Innovation
13 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 306 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 11 |
| 2025 | 9 |
| 2026 | 1 |
Investor mix
18 investors on record; lead investors include AbbVie, Symbiosis, Livzon Pharmaceutical, Solasta Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 56% |
| Private equity | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 33% |
